List of Tables
Table 1. Global Latanoprost for Open-angle Glaucoma Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Latanoprost for Open-angle Glaucoma Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Latanoprost for Open-angle Glaucoma Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Latanoprost for Open-angle Glaucoma Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Latanoprost for Open-angle Glaucoma Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Latanoprost for Open-angle Glaucoma Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Latanoprost for Open-angle Glaucoma Sales by Region (2020-2025) & (K Units)
Table 8. Global Latanoprost for Open-angle Glaucoma Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Latanoprost for Open-angle Glaucoma Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Latanoprost for Open-angle Glaucoma Sales Share by Manufacturers (2020-2025)
Table 12. Global Latanoprost for Open-angle Glaucoma Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Latanoprost for Open-angle Glaucoma Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Latanoprost for Open-angle Glaucoma by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Latanoprost for Open-angle Glaucoma as of 2024)
Table 16. Global Latanoprost for Open-angle Glaucoma Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Latanoprost for Open-angle Glaucoma Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Latanoprost for Open-angle Glaucoma Manufacturing Base and Headquarters
Table 19. Global Latanoprost for Open-angle Glaucoma Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Latanoprost for Open-angle Glaucoma Sales by Type (2020-2025) & (K Units)
Table 23. Global Latanoprost for Open-angle Glaucoma Sales by Type (2026-2031) & (K Units)
Table 24. Global Latanoprost for Open-angle Glaucoma Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Latanoprost for Open-angle Glaucoma Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Latanoprost for Open-angle Glaucoma ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Latanoprost for Open-angle Glaucoma Sales by Application (2020-2025) & (K Units)
Table 29. Global Latanoprost for Open-angle Glaucoma Sales by Application (2026-2031) & (K Units)
Table 30. Latanoprost for Open-angle Glaucoma High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Latanoprost for Open-angle Glaucoma Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Latanoprost for Open-angle Glaucoma Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Latanoprost for Open-angle Glaucoma ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Latanoprost for Open-angle Glaucoma Growth Accelerators and Market Barriers
Table 37. North America Latanoprost for Open-angle Glaucoma Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Latanoprost for Open-angle Glaucoma Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Latanoprost for Open-angle Glaucoma Growth Accelerators and Market Barriers
Table 40. Europe Latanoprost for Open-angle Glaucoma Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Latanoprost for Open-angle Glaucoma Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Latanoprost for Open-angle Glaucoma Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Latanoprost for Open-angle Glaucoma Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Latanoprost for Open-angle Glaucoma Growth Accelerators and Market Barriers
Table 45. Southeast Asia Latanoprost for Open-angle Glaucoma Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Latanoprost for Open-angle Glaucoma Investment Opportunities and Key Challenges
Table 47. Central and South America Latanoprost for Open-angle Glaucoma Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Latanoprost for Open-angle Glaucoma Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Latanoprost for Open-angle Glaucoma Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Pfizer Corporation Information
Table 51. Pfizer Description and Major Businesses
Table 52. Pfizer Product Models, Descriptions and Specifications
Table 53. Pfizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Pfizer Sales Value Proportion by Product in 2024
Table 55. Pfizer Sales Value Proportion by Application in 2024
Table 56. Pfizer Sales Value Proportion by Geographic Area in 2024
Table 57. Pfizer Latanoprost for Open-angle Glaucoma SWOT Analysis
Table 58. Pfizer Recent Developments
Table 59. Mylan Corporation Information
Table 60. Mylan Description and Major Businesses
Table 61. Mylan Product Models, Descriptions and Specifications
Table 62. Mylan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Mylan Sales Value Proportion by Product in 2024
Table 64. Mylan Sales Value Proportion by Application in 2024
Table 65. Mylan Sales Value Proportion by Geographic Area in 2024
Table 66. Mylan Latanoprost for Open-angle Glaucoma SWOT Analysis
Table 67. Mylan Recent Developments
Table 68. Novartis Corporation Information
Table 69. Novartis Description and Major Businesses
Table 70. Novartis Product Models, Descriptions and Specifications
Table 71. Novartis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Novartis Sales Value Proportion by Product in 2024
Table 73. Novartis Sales Value Proportion by Application in 2024
Table 74. Novartis Sales Value Proportion by Geographic Area in 2024
Table 75. Novartis Latanoprost for Open-angle Glaucoma SWOT Analysis
Table 76. Novartis Recent Developments
Table 77. Apotex Corporation Information
Table 78. Apotex Description and Major Businesses
Table 79. Apotex Product Models, Descriptions and Specifications
Table 80. Apotex Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Apotex Sales Value Proportion by Product in 2024
Table 82. Apotex Sales Value Proportion by Application in 2024
Table 83. Apotex Sales Value Proportion by Geographic Area in 2024
Table 84. Apotex Latanoprost for Open-angle Glaucoma SWOT Analysis
Table 85. Apotex Recent Developments
Table 86. Teva Corporation Information
Table 87. Teva Description and Major Businesses
Table 88. Teva Product Models, Descriptions and Specifications
Table 89. Teva Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Teva Sales Value Proportion by Product in 2024
Table 91. Teva Sales Value Proportion by Application in 2024
Table 92. Teva Sales Value Proportion by Geographic Area in 2024
Table 93. Teva Latanoprost for Open-angle Glaucoma SWOT Analysis
Table 94. Teva Recent Developments
Table 95. Taj Pharma Corporation Information
Table 96. Taj Pharma Description and Major Businesses
Table 97. Taj Pharma Product Models, Descriptions and Specifications
Table 98. Taj Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Taj Pharma Recent Developments
Table 100. CR Zizhu Corporation Information
Table 101. CR Zizhu Description and Major Businesses
Table 102. CR Zizhu Product Models, Descriptions and Specifications
Table 103. CR Zizhu Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. CR Zizhu Recent Developments
Table 105. Jiangsu Hengrui Pharmaceuticals Corporation Information
Table 106. Jiangsu Hengrui Pharmaceuticals Description and Major Businesses
Table 107. Jiangsu Hengrui Pharmaceuticals Product Models, Descriptions and Specifications
Table 108. Jiangsu Hengrui Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Jiangsu Hengrui Pharmaceuticals Recent Developments
Table 110. China Medical System Holdings Corporation Information
Table 111. China Medical System Holdings Description and Major Businesses
Table 112. China Medical System Holdings Product Models, Descriptions and Specifications
Table 113. China Medical System Holdings Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. China Medical System Holdings Recent Developments
Table 115. Key Raw Materials Distribution
Table 116. Raw Materials Key Suppliers
Table 117. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 118. Milestones in Production Technology Evolution
Table 119. Distributors List
Table 120. Market Trends and Market Evolution
Table 121. Market Drivers and Opportunities
Table 122. Market Challenges, Risks, and Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Latanoprost for Open-angle Glaucoma Product Picture
Figure 2. Global Latanoprost for Open-angle Glaucoma Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Brand Drug Product Picture
Figure 4. Generic Drug Product Picture
Figure 5. Global Latanoprost for Open-angle Glaucoma Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Male Patients
Figure 7. Female Patients
Figure 8. Latanoprost for Open-angle Glaucoma Report Years Considered
Figure 9. Global Latanoprost for Open-angle Glaucoma Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 10. Global Latanoprost for Open-angle Glaucoma Revenue (2020-2031) & (US$ Million)
Figure 11. Global Latanoprost for Open-angle Glaucoma Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 12. Global Latanoprost for Open-angle Glaucoma Revenue Market Share by Region (2020-2031)
Figure 13. Global Latanoprost for Open-angle Glaucoma Sales (2020-2031) & (K Units)
Figure 14. Global Latanoprost for Open-angle Glaucoma Sales (CAGR) by Region (2020-2031) (K Units)
Figure 15. Global Latanoprost for Open-angle Glaucoma Sales Market Share by Region (2020-2031)
Figure 16. Top 5 and Top 10 Manufacturers Latanoprost for Open-angle Glaucoma Sales Volume Market Share in 2024
Figure 17. Global Latanoprost for Open-angle Glaucoma Revenue Market Share Ranking (2024)
Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 19. Brand Drug Revenue Market Share by Manufacturer in 2024
Figure 20. Generic Drug Revenue Market Share by Manufacturer in 2024
Figure 21. Global Latanoprost for Open-angle Glaucoma Sales Market Share by Type (2020-2031)
Figure 22. Global Latanoprost for Open-angle Glaucoma Revenue Market Share by Type (2020-2031)
Figure 23. Global Latanoprost for Open-angle Glaucoma Sales Market Share by Application (2020-2031)
Figure 24. Global Latanoprost for Open-angle Glaucoma Revenue Market Share by Application (2020-2031)
Figure 25. North America Latanoprost for Open-angle Glaucoma Sales YoY (2020-2031) & (K Units)
Figure 26. North America Latanoprost for Open-angle Glaucoma Revenue YoY (2020-2031) & (US$ Million)
Figure 27. North America Top 5 Manufacturers Latanoprost for Open-angle Glaucoma Sales Revenue (US$ Million) in 2024
Figure 28. North America Latanoprost for Open-angle Glaucoma Sales Volume (K Units) by Type (2020- 2031)
Figure 29. North America Latanoprost for Open-angle Glaucoma Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 30. North America Latanoprost for Open-angle Glaucoma Sales Volume (K Units) by Application (2020-2031)
Figure 31. North America Latanoprost for Open-angle Glaucoma Sales Revenue (US$ Million) by Application (2020-2031)
Figure 32. US Latanoprost for Open-angle Glaucoma Revenue (2020-2031) & (US$ Million)
Figure 33. Canada Latanoprost for Open-angle Glaucoma Revenue (2020-2031) & (US$ Million)
Figure 34. Mexico Latanoprost for Open-angle Glaucoma Revenue (2020-2031) & (US$ Million)
Figure 35. Europe Latanoprost for Open-angle Glaucoma Sales YoY (2020-2031) & (K Units)
Figure 36. Europe Latanoprost for Open-angle Glaucoma Revenue YoY (2020-2031) & (US$ Million)
Figure 37. Europe Top 5 Manufacturers Latanoprost for Open-angle Glaucoma Sales Revenue (US$ Million) in 2024
Figure 38. Europe Latanoprost for Open-angle Glaucoma Sales Volume (K Units) by Type (2020-2031)
Figure 39. Europe Latanoprost for Open-angle Glaucoma Sales Revenue (US$ Million) by Type (2020-2031)
Figure 40. Europe Latanoprost for Open-angle Glaucoma Sales Volume (K Units) by Application (2020-2031)
Figure 41. Europe Latanoprost for Open-angle Glaucoma Sales Revenue (US$ Million) by Application (2020-2031)
Figure 42. Germany Latanoprost for Open-angle Glaucoma Revenue (2020-2031) & (US$ Million)
Figure 43. France Latanoprost for Open-angle Glaucoma Revenue (2020-2031) & (US$ Million)
Figure 44. U.K. Latanoprost for Open-angle Glaucoma Revenue (2020-2031) & (US$ Million)
Figure 45. Italy Latanoprost for Open-angle Glaucoma Revenue (2020-2031) & (US$ Million)
Figure 46. Russia Latanoprost for Open-angle Glaucoma Revenue (2020-2031) & (US$ Million)
Figure 47. Asia-Pacific Latanoprost for Open-angle Glaucoma Sales YoY (2020-2031) & (K Units)
Figure 48. Asia-Pacific Latanoprost for Open-angle Glaucoma Revenue YoY (2020-2031) & (US$ Million)
Figure 49. Asia-Pacific Top 8 Manufacturers Latanoprost for Open-angle Glaucoma Sales Revenue (US$ Million) in 2024
Figure 50. Asia-Pacific Latanoprost for Open-angle Glaucoma Sales Volume (K Units) by Type (2020- 2031)
Figure 51. Asia-Pacific Latanoprost for Open-angle Glaucoma Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 52. Asia-Pacific Latanoprost for Open-angle Glaucoma Sales Volume (K Units) by Application (2020-2031)
Figure 53. Asia-Pacific Latanoprost for Open-angle Glaucoma Sales Revenue (US$ Million) by Application (2020-2031)
Figure 54. Indonesia Latanoprost for Open-angle Glaucoma Revenue (2020-2031) & (US$ Million)
Figure 55. Japan Latanoprost for Open-angle Glaucoma Revenue (2020-2031) & (US$ Million)
Figure 56. South Korea Latanoprost for Open-angle Glaucoma Revenue (2020-2031) & (US$ Million)
Figure 57. China Taiwan Latanoprost for Open-angle Glaucoma Revenue (2020-2031) & (US$ Million)
Figure 58. India Latanoprost for Open-angle Glaucoma Revenue (2020-2031) & (US$ Million)
Figure 59. Central and South America Latanoprost for Open-angle Glaucoma Sales YoY (2020-2031) & (K Units)
Figure 60. Central and South America Latanoprost for Open-angle Glaucoma Revenue YoY (2020-2031) & (US$ Million)
Figure 61. Central and South America Top 5 Manufacturers Latanoprost for Open-angle Glaucoma Sales Revenue (US$ Million) in 2024
Figure 62. Central and South America Latanoprost for Open-angle Glaucoma Sales Volume (K Units) by Type (2021-2031)
Figure 63. Central and South America Latanoprost for Open-angle Glaucoma Sales Revenue (US$ Million) by Type (2020-2031)
Figure 64. Central and South America Latanoprost for Open-angle Glaucoma Sales Volume (K Units) by Application (2020-2031)
Figure 65. Central and South America Latanoprost for Open-angle Glaucoma Sales Revenue (US$ Million) by Application (2020-2031)
Figure 66. Brazil Latanoprost for Open-angle Glaucoma Revenue (2020-2025) & (US$ Million)
Figure 67. Argentina Latanoprost for Open-angle Glaucoma Revenue (2020-2025) & (US$ Million)
Figure 68. Middle East, and Africa Latanoprost for Open-angle Glaucoma Sales YoY (2020-2031) & (K Units)
Figure 69. Middle East and Africa Latanoprost for Open-angle Glaucoma Revenue YoY (2020-2031) & (US$ Million)
Figure 70. Middle East and Africa Top 5 Manufacturers Latanoprost for Open-angle Glaucoma Sales Revenue (US$ Million) in 2024
Figure 71. Middle East and Africa Latanoprost for Open-angle Glaucoma Sales Volume (K Units) by Type (2021-2031)
Figure 72. South America Latanoprost for Open-angle Glaucoma Sales Revenue (US$ Million) by Type (2020-2031)
Figure 73. Middle East and Africa Latanoprost for Open-angle Glaucoma Sales Volume (K Units) by Application (2020-2031)
Figure 74. Middle East and Africa Latanoprost for Open-angle Glaucoma Sales Revenue (US$ Million) by Application (2020-2031)
Figure 75. GCC Countries Latanoprost for Open-angle Glaucoma Revenue (2020-2025) & (US$ Million)
Figure 76. Turkey Latanoprost for Open-angle Glaucoma Revenue (2020-2025) & (US$ Million)
Figure 77. Egypt Latanoprost for Open-angle Glaucoma Revenue (2020-2025) & (US$ Million)
Figure 78. South Africa Latanoprost for Open-angle Glaucoma Revenue (2020-2025) & (US$ Million)
Figure 79. Latanoprost for Open-angle Glaucoma Industry Chain Mapping
Figure 80. Regional Latanoprost for Open-angle Glaucoma Manufacturing Base Distribution (%)
Figure 81. Global Latanoprost for Open-angle Glaucoma Production Market Share by Region (2020-2031)
Figure 82. Latanoprost for Open-angle Glaucoma Production Process
Figure 83. Regional Latanoprost for Open-angle Glaucoma Production Cost Structure
Figure 84. Channels of Distribution (Direct Vs Distribution)
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed
